Skip to main content
Fig. 1 | Journal of Hematology & Oncology

Fig. 1

From: Emerging therapies for small cell lung cancer

Fig. 1

Mechanisms of action for targeted agents. VEGFR, vascular endothelial growth factor receptor; PDGFR, platelet-derived growth factor receptor; FGFR, fibroblast growth factor receptor; DLL3, delta-like protein 3; PARP, poly (ADP-ribose) polymerase; PDL-1, programmed death ligand 1; PD1, programmed death 1; CTLA-4, cytotoxic T lymphocyte antigen-4

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us